Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer - - Positive Preliminary Phase 1b/2 Data ...
The tech platform said producers can better detect contamination and allergens with its program in order to achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback